Jiangsu Province determines the execution time of "4 + 7" expansion results

On October 28, Jiangsu Medical Security Bureau issued a notice on Soliciting Opinions on the implementation plan of Jiangsu Province for promoting the implementation of pilot drug centralized purchase and use pilot to expand the regional scope (Draft for comments) The notice pointed out that Jiangsu Province will fully implement the national pilot expansion results and supporting policies by December 31, 2019 Attached is the list of the results of the previous selection (Jiangsu Province): The scope of implementation includes all public medical institutions in Jiangsu Province, military medical institutions participating in the pilot expansion, designated social medical institutions and designated retail pharmacies voluntarily participating in the pilot expansion Drugs include 25 generic drugs (see the table above) selected in the pilot drug centralized procurement and use organized by the state According to the number of selected enterprises, the procurement cycle of selected drugs is one year and two years respectively, which can be extended for one year depending on the actual situation For the remaining consumption beyond the agreed purchase, the relevant medical institutions can still purchase other online varieties with appropriate price through the provincial drug centralized purchase platform For the 25 generic drugs included in the pilot expansion, if there are more than 3 manufacturers of the same type of drugs that have passed the consistency evaluation of quality and efficacy, the varieties that have failed the consistency evaluation will not be used in the centralized purchase of drugs under the condition of ensuring the supply.